# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 05-15-2024 | 03-31-2024 | 10-Q | |
2 | 04-01-2024 | 12-31-2023 | 10-K |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
No TCB008-related Adverse Events seen in any of the re-start patients6 Patients received second dose, 3 Patients received third...
Warrants Priced At £0.78 Per ADS, Expiring In One Year